Exhaled breath analysis in adult patients with cystic fibrosis by real-time proton mass spectrometry

Malika Mustafina,Artemiy Silantyev,Stanislav Krasovskiy,Alexander Chernyak,Zhanna Naumenko,Alexander Suvorov,Daria Gognieva,Magomed Abdullaev,Alina Bektimirova,Aleksandra Bykova,Vasilisa Dergacheva,Vladimir Betelin,Philipp Kopylov
DOI: https://doi.org/10.1016/j.cca.2024.119733
IF: 6.314
2024-05-22
Clinica Chimica Acta
Abstract:Background Proton-transfer reaction time-of-flight mass spectrometry (PTR-TOF-MS) is a promising tool for a rapid online determination of exhaled volatile organic compounds (eVOCs) profiles in patients with cystic fibrosis (CF). Objective To detect VOC breath signatures specific to adult patients with CF compared with controls using PTR-TOF-MS. Methods 102 CF patients (54 M/48, mean age 25.6 ± 7.8 yrs) and 97 healthy controls (56 M/41F, mean age 25.8 ± 6.0 yrs) were examined. Samples from normal quiet breathing and forced expiratory maneuvers were analyzed with PTR-TOF-MS (Ionicon, Austria) to obtain VOC profiles listed as ions at various mass-to-charge ratios ( m / z ). Results PTR-TOF-MS analysis was able to detect 167 features in exhaled breath from CF patients and healthy controls. According to cluster analysis and LASSO regression, patients with CF and controls were separated. The most significant VOCs for CF were indole, phenol, dimethyl sulfide, and not indicated: m / z = 297.0720 ([C12H13N2O7 and C17H13O5]H + ), m / z = 281.0534 ([C19H7NO2, C12H11NO7 and C16H9O5]H + ) during five-fold cross-validation both in forced expiratory maneuver and in normal quiet breathing. Conclusion PTR-TOF-MS is a promising method for determining the molecular composition of exhaled air specific to CF.
medical laboratory technology
What problem does this paper attempt to address?